October 2020 in “Journal of the American Academy of Dermatology” Spironolactone does not increase the risk of breast cancer recurrence.
May 2016 in “Journal of The American Academy of Dermatology” Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.
January 2016 in “Elsevier eBooks” Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.
Spironolactone does not change hair growth.
Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.
The 2% spironolactone cream did not reduce hair growth in women with facial hirsutism.
September 1997 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” Spironolactone is more effective than finasteride in treating excessive hair growth in women.
January 1994 in “Journal of Dermatological Treatment” Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.
Spironolactone was effective in reducing hair growth in women with hirsutism.
October 1986 in “Inpharma” Spironolactone helps reduce hair growth in women with hirsutism but may cause menstrual irregularities.
November 1982 in “Inpharma” Spironolactone reduces hair growth in women with unexplained excessive hairiness.
May 2021 in “Journal of Investigative Dermatology” Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.
1 citations,
August 2019 in “Evidence-Based Practice” 1 citations,
January 2018 in “The Open Dermatology Journal” May 2024 in “Reactions weekly”
August 2023 in “Journal of Cosmetic Dermatology” Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.
December 2020 in “Journal of The American Academy of Dermatology” Taking vitamin C and vitamin E twice a day can help prevent sunburn and DNA damage from UVB exposure.
March 2023 in “Current Pharmaceutical Design” 46 citations,
January 2000 in “The Journal of Clinical Endocrinology and Metabolism” June 2020 in “The Medical Journal of Cairo University” 34 citations,
January 1995 in “The Journal of Clinical Endocrinology and Metabolism” 8 citations,
February 2022 in “PubMed”
1 citations,
December 2020 in “Journal of The American Academy of Dermatology” GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.
May 2023 in “Journal of Investigative Dermatology” April 2023 in “International Journal of Women's Dermatology” March 2009 in “Hair transplant forum international” 1 citations,
August 2022 in “Journal of Cosmetic Dermatology”